Thierry Abribat, Founder of Amolyt Pharma

Thierry Abribat is the founder of Amolyt Pharma. Amolyt Pharma has raised $210M in total funding. Latest round: Series C. Based in Lyon, France.

About Thierry Abribat

Thierry Abribat is a French biotech entrepreneur and founder based in Lyon who specializes in rare endocrine diseases. He is the Founder and CEO of Amolyt Pharma, which was acquired by AstraZeneca in March 2024 for up to $1.05 billion. This marks his third successful exit in the biotech sector.

Thierry Abribat at a glance

More founders in Lyon, France (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library